gemcitabine-Tarceva regimen
(jem-SY-tuh-been-tar-SEE-vuh REH-jih-men)
A chemotherapy combination used for the treatment of locally advanced and metastatic pancreatic cancer. It includes the drugs gemcitabine hydrochloride and erlotinib hydrochloride. Also called gemcitabine-erlotinib regimen.